<p>1. Current Practices and Regulations for Embryo Transfer Worldwide: Implications on IVF Outcome </p><p>Baris Ata and Emre Seli</p><p>2. Analysis of the Zona Pellucida as an Indicator of Oocyte Developmental Potential</p><p>Markus Montag, Thomas Schimming, and Maria Köster</p><p>3. Morphological Assessment of Oocytes, Pronuclear and Cleavage Stage Embryos </p><p>Laura Rienzi, Benedetta Iussig, and Filippo Ubaldi</p><p>4. Morphological Assessment of Blastocyst Stage Embryos: Types of Grading Systems and Their Reported Outcomes</p><p>Basak Balaban and David K. Gardner</p><p>5. Real Time Imaging Strategies to Improve Morphological Assessment</p><p>María Cruz, Manuel Muñoz, and Marcos Meseguer</p><p>6. Limitations and Benefits of Morphologic Embryo Assessment Strategies: How Far Can Morphological Assessment Go in the Identification of Viable Embryos?</p><p>Denny Sakkas and David K. Gardner</p><p>7. Sperm Morphologic Characteristics and Their Impact on Embryo Quality and Pregnancy Outcome</p><p>Bhushan K. Gangrade and Ashok Agarwal</p><p>8. Objective Biomarkers of Sperm Development and Fertility: Assessment of Sperm-Zona Pellucida Binding Ability and Hyaluronic Acid Mediated Selection of Sperm for ICSI Fertilization </p><p>Gabor Huszar </p><p>9. Selecting the Best Sperm and Its Implications in Clinical Practice</p><p>Juan G. Alvarez</p><p>10. The Origins of Aneuploidy in Human Embryos</p><p>Elpida Fragouli and Joy Delhanty</p><p>11. Preimplantation Genetic Screening and Diagnosis Using Fluorescent In Situ Hybridization (FISH)</p><p>Tsilya Gerasimova and Maria D. Lalioti </p><p>12. Single Nucleotide Polymorphisms and Next Generation Sequencing</p><p>Alan H. Handyside and Dagan Wells</p><p>13. Use of Comparative Genomic Hybridization (CGH) and Microarray-CGH for Preimplantation Genetic Screening</p><p>Leeanda Wilton and Dagan Wells </p><p>14. Quantitative SNP Array and Real-Time PCR Based Human Preimplantation Embryo Aneuploidy Screening </p><p>Nathan R. Treff</p><p>15. Regulation of Gene Expression in the Oocyte and Early Embryo: Implications for Transcriptomic and Proteomic Embryo Assessment</p><p>Helena Kristiansson and Emre Seli</p><p>16. Transcriptomics Technology: Promise and Potential Pitfalls </p><p>Can Bruce and Asli Uyar</p><p>17. Transcriptomic Analysis of Cumulus and Granulosa Cells as a Marker of Embryo Viability</p><p>Elpida Fragouli and Dagan Wells</p><p>18. Mass Spectrometry, Proteomics and the Study of Sperm Cell Biology</p><p>Mark A. Baker and R. John Aitken</p><p>19. Proteomic Analysis of Embryo Viability </p><p>Mandy G Katz-Jaffe and Susanna McReynolds</p><p>20. Metabolism of the Viable Human Embryo</p><p>David K. Gardner</p><p>21. Analysis of Respiration as an Indicator of Oocyte and Embryo Developmental Potential </p><p>David L. Keefe</p><p>22. Mitochondrial Activity as a Biomarker of Gamete and Embryo Health </p><p>Jonathan Van Blerkom</p><p>23. Carbohydrate Analysis and Embryo Viability</p><p>Michelle Lane and David K. Gardner</p><p>24. Identification of Viable Embryos by Non-invasive Measurement of Amino Acids in Culture Media</p><p>Franchesca D. Houghton</p><p>25. Metabolomic Profiling of Embryos Using Spectroscopy</p><p>Denny Sakkas and Emre Seli</p><p>26. Microfluidic Devices for the Analysis of Gamete and Embryo Physiology </p>George A. Thouas, David L. Potter, and David K. Gardner
